The CDC is playing an unusually small role in responding to the hantavirus outbreak, taking a back seat to the WHO.
Health and medical news from independent sources.
The CDC is playing an unusually small role in responding to the hantavirus outbreak, taking a back seat to the WHO.
There are scientific reasons to study raccoon reproductive anatomy. But did RFK Jr.’s actions fit within a bioethical framework?
“We want, we need to keep medicine local. I think that's good for patients, it's good for communities,” Dr. Glaucomflecken says on the “First Opinion Podcast.”
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
Spanish authorities on Friday were preparing to receive more than 140 passengers and crew members on board a hantavirus-stricken cruise ship headed for the Canary Islands.
Roche has signed a deal to acquire PathAI to speed up its use of artificial intelligence to help pathologists diagnose diseases.
Makary's ouster would create another high-profile vacancy atop RFK Jr.'s health department.
Capricor Therapeutics has accused Nippon Shinyaku and its U.S. subsidiary of botching the rollout of a Duchenne muscular dystrophy treatment.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
The cruise ship hantavirus outbreak is serious but limited. Online, it's another story.
“The fundamental question is: Who gets to regulate mifepristone?”
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Was Naomi Osaka's Met Gala outfit inspired by Gilead's logo? Janelle Monáe's by Insilico's? Probably not — and yet.
A Duchenne therapy lawsuit, FDA Commissioner Marty Makary’s White House troubles, and other news from The Readout
An FDA proposal to remove references to “gender” from its regulations sparked concerns about unintended consequences on research
The latest in the hantavirus cruise ship saga, why these former officials left the FDA, and more health news from Morning Rounds
The Trump administration is seeking unprecedented access to medical records of federal workers and retirees, and their families. The data could be used to implement cost-saving measures, but it would also give the administration access to reams of personal information. Legal experts and insurers say...
Single-payer healthcare is a central talking point in the chaotic race for California governor. In a crowded field, top-polling Democrats are declaring their support for a government-run health system but providing few details about how they’d accomplish it in the nation’s most populous state.
In this week's STATus Report, hear from six former FDA officials on why they left the agency.
“The pediatric and orphan pipeline is already the smallest, slowest, and least capitalized segment of the device industry,” writes Kolaleh Eskandanian.